Article Information
History
- September 22, 2020.
Article Versions
- Version 1 (September 18, 2020 - 10:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- J Stowe, PhD1,*,
- E Tessier, MsC1,*,
- H Zhao, PhD1,
- R Guy, BSc2,
- B Muller-Pebody, PhD2,
- M Zambon, PhD3,
- N Andrews, PhD4,
- M Ramsay, MBBS1 and
- J Lopez Bernal, PhD1,#
- 1Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ, U.K.
- 2Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ, U.K.
- 3Virus Reference Department, National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ, U.K.
- 4Statistics, Modelling and Economics Department, National Infection Service, Public Health England, 61 Colindale Ave, London, NW9 5EQ, U.K.
- ↵#Corresponding author:
Dr Jamie Lopez Bernal, Public Health England 61 Colindale Ave, London NW9 5EQ, London England, Jamie.LopezBernal2{at}phe.gov.uk, Tel: 0208 3276528
↵* authors contributed equally
Posted September 22, 2020.
Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design
